Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the use of Chinese herbal medicine in the management of endometriosis: a prospective study
ISRCTN ISRCTN19413357
ClinicalTrials.gov identifier
Public title A multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the use of Chinese herbal medicine in the management of endometriosis: a prospective study
Scientific title
Acronym Endoherb
Serial number at source HEC 02/098
Study hypothesis The hypothesis is that the formulated Chinese herbal treatment shows no significant difference than a placebo in the management of the symptoms of endometriosis.
Lay summary
Ethics approval Ethics approval received from the University of Western Sydney's Ethics Committee on the 8th August 2002 (ref: HEC 02/098).
Study design A multicentre, randomised, double-blind, placebo-controlled clinical trial
Countries of recruitment Australia
Disease/condition/study domain Endometriosis
Participants - inclusion criteria 1. Women, aged 18 - 43 years
2. Diagnosed with endometriosis by laparoscopy and the severity staged (grade I - IV)
3. At least three months of pain measuring more than 30 mm on visual analogue scale (VAS) scale
Participants - exclusion criteria 1. Menopause
2. Pregnancy
3. Liver diseases
4. Suffering from diabetes mellitus
5. Suffering from malignancies
6. Hormonal treatments
7. Anti-depressant treatments
8. Immunosuppressive conditions and treatments
Anticipated start date 15/11/2004
Anticipated end date 15/11/2005
Status of trial Completed
Patient information material
Target number of participants 100 participants (50 in each arm)
Interventions A specific Chinese herbal formula (Endoherb) versus placebo.
Primary outcome measure(s) Pain intensity due to endometriosis, measured quantitatively on the VAS and qualitatively as descriptive values.
Secondary outcome measure(s) 1. Quality of life using the 36-item Short-Form health survey (SF-36) and a study design health survey tool
2. Serum CA 125 levels
Sources of funding University of Western Sydney (Australia)
Trial website
Publications
Contact name Dr  Alex  Liew
  Address 497 South Road
Ashford
  City/town South Australia
  Zip/Postcode 5035
  Country Australia
  Tel +61 (0)8 83713711
  Fax +61 (0)8 83713711
  Email endoherb@tpg.com.au
Sponsor University of Western Sydney (Australia)
  Address Centre for Complementary Medicine
Locked Bag 1797
Penrith South DC
New South Wales
  City/town Sydney
  Zip/Postcode 1797
  Country Australia
Date applied 04/05/2006
Last edited 20/09/2007
Date ISRCTN assigned 02/06/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central